184 related articles for article (PubMed ID: 11990715)
1. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder.
Ueno KI; Togashi H; Mori K; Matsumoto M; Ohashi S; Hoshino A; Fujita T; Saito H; Minami M; Yoshioka M
Behav Pharmacol; 2002 Feb; 13(1):1-13. PubMed ID: 11990715
[TBL] [Abstract][Full Text] [Related]
2. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
Ueno K; Togashi H; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
[TBL] [Abstract][Full Text] [Related]
3. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
Ueno K; Togashi H; Matsumoto M; Ohashi S; Saito H; Yoshioka M
J Pharmacol Exp Ther; 2002 Jul; 302(1):95-100. PubMed ID: 12065705
[TBL] [Abstract][Full Text] [Related]
4. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H
Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523
[TBL] [Abstract][Full Text] [Related]
6. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.
Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K
Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.
Bizot JC; Chenault N; Houzé B; Herpin A; David S; Pothion S; Trovero F
Psychopharmacology (Berl); 2007 Aug; 193(2):215-23. PubMed ID: 17406857
[TBL] [Abstract][Full Text] [Related]
8. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
[TBL] [Abstract][Full Text] [Related]
9. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
10. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
Soeters HS; Howells FM; Russell VA
Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
[TBL] [Abstract][Full Text] [Related]
12. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
Wultz B; Sagvolden T; Moser EI; Moser MB
Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
[TBL] [Abstract][Full Text] [Related]
13. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
14. Impaired monoamine neural system in the mPFC of SHRSP/Ezo as an animal model of attention-deficit/hyperactivity disorder.
Suzuki N; Hiraide S; Shikanai H; Isshiki T; Yamaguchi T; Izumi T; Iizuka K
J Pharmacol Sci; 2024 Feb; 154(2):61-71. PubMed ID: 38246729
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder.
Kim J; Park H; Yu SL; Jee S; Cheon KA; Song DH; Kim SJ; Im WY; Kang J
Int J Dev Neurosci; 2016 Oct; 53():83-89. PubMed ID: 27469434
[TBL] [Abstract][Full Text] [Related]
17. Acoustic noise improves motor learning in spontaneously hypertensive rats, a rat model of attention deficit hyperactivity disorder.
Söderlund GB; Eckernäs D; Holmblad O; Bergquist F
Behav Brain Res; 2015 Mar; 280():84-91. PubMed ID: 25454351
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
Wooters TE; Bardo MT
Brain Res; 2011 Jun; 1396():45-53. PubMed ID: 21570676
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
Langen B; Dost R
Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
